(S)-2-Amino-3-((S)-2-oxopyrrolidin-3-yl)propanamide hydrochloride, 97%, 100mg

(R)-(6,6'-Dimethoxy-[1,1'-biphenyl]-2,2'-diyl)bis(diphenylphosphine), 97%, 1g

LONAFARNIB, 99%, 100mg

2-Hydroxy-4-methyl-3-nitropyridine, 97.0%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(((allyloxy)carbonyl)amino)pentanoic acid, 97%, 250mg

3-(4-METHOXYPHENYLSULFANYL)PIPERIDINE HCL, 95.0%, 250mg

N1-(4-Aminophenyl)benzene-1,4-diamine, 95.0%, 25g

Polyalkylene oxide modified silicone, Dimethylsiloxane-Ethylene Oxide Block/Graft Polymer cSt 400, 100g

1,2-Dichloro-4-(2,2,2-trifluoroethyl)benzene, 95.0%, 5g

2-(3-FLUOROPHENYL)CYCLOPROPANAMINE HCL, 95.0%, 1g

5-(2-Methyl-1,3-thiazol-4-yl)thiophene-2-carboxylic acid, 97%, 2.5g

4-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 100mg

N-(4'-Bromo-4-biphenylyl)-N-phenyl-1-naphthylamine, 97%, 1g